Which drugs does patent 6,673,337 protect, and when does it expire?
Patent 6,673,337 protects ALPHAGAN P and is included in two NDAs. There have been two Paragraph IV challenges on Alphagan P.
Protection for ALPHAGAN P has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-seven patent family members in nineteen countries.